{"schema_version":"secwatch.filing_event.v1","accession":"0001062822-24-000020","form_type":"8-K","ticker":"LXRX","cik":"0001062822","company_name":"LEXICON PHARMACEUTICALS, INC.","filed_at":"2024-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.134322+00:00","generated_at":"2026-06-03T05:21:20.475741+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Lexicon CEO Lonnel Coats to retire effective July 7, 2024; board begins CEO search","bullets":["Lonnel Coats notified retirement as CEO (principal executive officer) and board member, effective July 7, 2024.","Board of directors has initiated a search for a new CEO, considering both internal and external candidates.","No successor named; Coats continues until effective date.","Lexicon Pharmaceuticals (LXRX) trades on Nasdaq."],"urls":{"canonical":"https://secwatch.observer/filing/0001062822-24-000020","json":"https://secwatch.observer/filing/0001062822-24-000020.json","markdown":"https://secwatch.observer/filing/0001062822-24-000020.md","text":"https://secwatch.observer/filing/0001062822-24-000020.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1062822/000106282224000020/0001062822-24-000020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1062822/000106282224000020/form8-kcoatsretirement.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T05:21:20.475741+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0f3129db55","claim":"Lonnel Coats retired as Chief Executive Officer at LEXICON PHARMACEUTICALS, INC..","evidence_excerpt":"On April 24, 2024, Lonnel Coats notified us of his retirement as our chief executive officer (in which capacity, Mr. Coats functions as our principal executive officer) and as a member of our board of directors, in each case effective July 7, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282224000020/0001062822-24-000020-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"7f94172b46","claim":"Lonnel Coats retired as Member of the Board of Directors at LEXICON PHARMACEUTICALS, INC..","evidence_excerpt":"On April 24, 2024, Lonnel Coats notified us of his retirement as our chief executive officer (in which capacity, Mr. Coats functions as our principal executive officer) and as a member of our board of directors, in each case effective July 7, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282224000020/0001062822-24-000020-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Member of the Board of Directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}